luteinize

(redirected from luteinizing)
Also found in: Dictionary.

lu·te·i·nize

(lū'tē-ĭ-nīz),
To form luteal tissue.
Farlex Partner Medical Dictionary © Farlex 2012

luteinize

(lo͞o′tē-ə-nīz′)
v. lutein·ized, lutein·izing, lutein·izes
v.tr.
To cause the production of a corpus luteum in.
v.intr.
To develop into or become part of the corpus luteum.

lu′te·in·i·za′tion (-ə-nĭ-zā′shən) n.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.
References in periodicals archive ?
Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene.
The human genome contains seven genes for the [beta]-subunit of chorionic gonadotropin but only one gene for the [beta]-subunit of luteinizing hormone.
The luteinizing hormone to follicle-stimulating hormone ratio also appeared to affect the alpha diversity of women with PCOS, as seen in observed sequence variants and Faith's phylogenetic diversity (P = .08).
Leptin acts centrally to induce the prepubertal secretion of luteinizing hormone in the female rat.
Leptin gene expression, circulating leptin, and luteinizing hormone pulsatility are acutely responsive to short-term fasting in prepubertal heifers: relationships to circulating insulin and insulin-like growth factor I.
Endocrine changes, such as high testosterone (HT) levels and high luteinizing hormone (LH)/ follicle-stimulating hormone (FSH) ratios, may suggest functional ovarian hyperandrogenism, which may induce such dysfunction.
Follicle stimulating hormone and luteinizing hormone were estimated by enzyme-linked immunosorbent assay on day 3 of the cycle and the ratio was calculated.
The basal luteinizing hormone, basal follicle stimulating hormone, basal luteinizing hormone/follicle stimulating hormone, peak luteinizing hormone, peak follicle stimulating hormone and peak luteinizing hormone/follicle stimulating hormone values were found to be significantly higher in the patients with central precocious puberty.
Known as the Cue, the device can test and track five key health indicators--testosterone, vitamin D, the flu virus, luteinizing hormone (which indicates a woman's fertility), and C-reactive protein (CRP, which serves as a marker of inflammation).
It binds receptors in the brain (specifically the hypothalamus and the pituitary gland) to increase the production of follicle stimulating hormone (FSH) and luteinizing hormone (LH).

Full browser ?